The University of Chicago Header Logo

Connection

Richard Schilsky to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Cyclin-Dependent Kinase Inhibitor p16.
Richard Schilsky
Connection Strength
0.825
Cyclin-Dependent Kinase Inhibitor p16
  1. Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Oct; 8:e2400477.
    View in: PubMed
    Score: 0.825
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.